Cargando…

Complex of C(60) Fullerene with Doxorubicin as a Promising Agent in Antitumor Therapy

The main aim of this work was to evaluate the effect of doxorubicin in complex with C(60) fullerene (C(60) + Dox) on the growth and metastasis of Lewis lung carcinoma in mice and to perform a primary screening of the potential mechanisms of C(60) + Dox complex action. We found that volume of tumor f...

Descripción completa

Detalles Bibliográficos
Autores principales: Prylutska, Svitlana V., Skivka, Larysa M., Didenko, Gennadiy V., Prylutskyy, Yuriy I., Evstigneev, Maxim P., Potebnya, Grygoriy P., Panchuk, Rostyslav R., Stoika, Rostyslav S., Ritter, Uwe, Scharff, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695471/
https://www.ncbi.nlm.nih.gov/pubmed/26714861
http://dx.doi.org/10.1186/s11671-015-1206-7
Descripción
Sumario:The main aim of this work was to evaluate the effect of doxorubicin in complex with C(60) fullerene (C(60) + Dox) on the growth and metastasis of Lewis lung carcinoma in mice and to perform a primary screening of the potential mechanisms of C(60) + Dox complex action. We found that volume of tumor from mice treated with the C(60) + Dox complex was 1.4 times less than that in control untreated animals. The number of metastatic foci in lungs of animals treated with C(60) + Dox complex was two times less than that in control untreated animals. Western blot analysis of tumor lysates revealed a significant decrease in the level of heat-shock protein 70 in animals treated with C(60) + Dox complex. Moreover, the treatment of tumor-bearing mice was accompanied by the increase of cytotoxic activity of immune cells. Thus, the potential mechanisms of antitumor effect of C(60) + Dox complex include both its direct action on tumor cells by inducing cell death and increasing of stress sensitivity and an immunomodulating effect. The obtained results provide a scientific basis for further application of C(60) + Dox nanocomplexes as treatment agents in cancer chemotherapy.